The work group aimed to make recommendations to clarify the processes for prescribing and preparing CRRT solutions based on the medication error data collected by the ...
TORONTO, Jan. 22, 2019 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:EDT), a Phase III company developing the first treatment for patients with endotoxemic septic shock ...
TORONTO, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:EDT), a Phase III company developing the first treatment for patients with endotoxemic septic shock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback